Yes, I believe there is a great need for bavi in the market and it will be successful. I think the current price reflects both the uncertainty of emerging bio techs in general and the lawsuits from when CSM went against signed protocols and FDA procedures and then further compounded the issue with a coverup as documented in court cases. I believe all this will be straightened out this year and the stock price will reflect its true value in less than a year. I have been accumulating shares.